Skip to main content
Clinical Trials/JPRN-UMIN000042886
JPRN-UMIN000042886Not yet recruiting未知

the association between Ki67 and clinical features in patients with advanced EGFR-positive lung adenocarcinoma - EGFR-Ki67 study

Tohoku Medical and Pharmaceutical University,Tohoku Medical and Pharmaceutical University Hospital0 sites40 target enrollmentStarted: January 2, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to 100years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients having an overlap cancer with activity Patients that an doctor judged to be inappropriate.

Investigators

Sponsor
Tohoku Medical and Pharmaceutical University,Tohoku Medical and Pharmaceutical University Hospital

Similar Trials